Nisa Investment Advisors LLC Reduces Stock Position in Ventas, Inc. $VTR

Nisa Investment Advisors LLC lessened its holdings in Ventas, Inc. (NYSE:VTR) by 13.7% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 158,335 shares of the real estate investment trust’s stock after selling 25,062 shares during the period. Nisa Investment Advisors LLC’s holdings in Ventas were worth $11,164,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Norges Bank purchased a new stake in shares of Ventas during the second quarter valued at $344,740,000. Vanguard Group Inc. lifted its holdings in Ventas by 4.1% during the 2nd quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock valued at $4,533,937,000 after buying an additional 2,854,751 shares in the last quarter. Citigroup Inc. boosted its position in Ventas by 451.9% in the 2nd quarter. Citigroup Inc. now owns 2,316,344 shares of the real estate investment trust’s stock valued at $146,277,000 after buying an additional 1,896,627 shares during the period. State Street Corp boosted its position in Ventas by 5.2% in the 2nd quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock valued at $1,781,267,000 after buying an additional 1,388,678 shares during the period. Finally, Invesco Ltd. grew its stake in Ventas by 36.1% in the 2nd quarter. Invesco Ltd. now owns 4,812,970 shares of the real estate investment trust’s stock worth $303,939,000 after acquiring an additional 1,275,446 shares in the last quarter. 94.18% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.26, for a total value of $797,477.72. Following the transaction, the chief executive officer owned 1,145,695 shares of the company’s stock, valued at $88,516,395.70. The trade was a 0.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Robert F. Probst sold 29,930 shares of the business’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the transaction, the chief financial officer owned 138,434 shares of the company’s stock, valued at approximately $10,694,026.50. This trade represents a 17.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 713,520 shares of company stock worth $52,788,577. Corporate insiders own 0.80% of the company’s stock.

Ventas Stock Down 0.2%

Shares of NYSE VTR opened at $74.90 on Friday. Ventas, Inc. has a 12-month low of $56.97 and a 12-month high of $81.89. The stock’s fifty day simple moving average is $78.25 and its two-hundred day simple moving average is $71.36. The stock has a market capitalization of $35.18 billion, a PE ratio of 144.05, a price-to-earnings-growth ratio of 1.85 and a beta of 0.78. The company has a current ratio of 0.32, a quick ratio of 0.32 and a debt-to-equity ratio of 1.01.

Ventas (NYSE:VTR) last released its quarterly earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 EPS for the quarter, topping the consensus estimate of $0.87 by $0.01. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.44 billion. During the same period in the previous year, the company posted $0.80 EPS. The business’s revenue for the quarter was up 20.5% compared to the same quarter last year. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. As a group, analysts expect that Ventas, Inc. will post 3.4 EPS for the current fiscal year.

Ventas Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st will be given a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend is Wednesday, December 31st. Ventas’s dividend payout ratio is presently 369.23%.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Wells Fargo & Company lifted their price target on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Citigroup upped their target price on Ventas from $80.00 to $88.00 and gave the stock a “buy” rating in a report on Tuesday, November 11th. The Goldman Sachs Group assumed coverage on Ventas in a research report on Friday. They set a “buy” rating and a $94.00 price target on the stock. Finally, KeyCorp lifted their price objective on Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $80.65.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.